Per Helbo

Per Helbo is an experienced executive in the pharmaceutical industry, currently serving as Vice President and Global Program Lead for Ultra-Rare Disease at Takeda since June 2018. In this role, Per leads cross-functional teams across various functions including market access, clinical development, and regulatory affairs, and is responsible for the global asset strategy of multiple therapeutic products. Prior experience includes roles at Vifor Pharma as Director of Commercial Excellence and at Takeda Pharmaceuticals as Vice President for the Cardiovascular & Metabolic therapeutic area. With a robust background in marketing, product management, and commercial operations, Per has overseen significant product launches and managed global marketing strategies for leading pharmaceutical assets throughout a career spanning over three decades. Education includes advanced executive training from renowned institutions such as INSEAD, the Wharton School, and Copenhagen Business School.